Barrington Research Maintains Outperform on Concentrix, Maintains $84 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has reiterated its 'Outperform' rating for Concentrix (NASDAQ:CNXC) with a maintained price target of $84.
September 20, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has reiterated its 'Outperform' rating for Concentrix with a maintained price target of $84, indicating confidence in the company's performance.
The reaffirmation of an 'Outperform' rating and a stable price target suggests positive sentiment from Barrington Research, which could boost investor confidence and potentially lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100